Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kemp, JA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 82 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kemp, JA; Campbell, DM; Amir, N
      Multimodal radiation impedance of a rectangular duct terminated in an infinite baffle

      ACUSTICA
    2. Knoflach, F; Woltering, T; Adam, G; Mutel, V; Kemp, JA
      Pharmacological properties of native metabotropic glutamate receptors in freshly dissociated Golgi cells of the rat cerebellum

      NEUROPHARMACOLOGY
    3. Kew, JNC; Ducarre, JM; Pflimlin, MC; Mutel, V; Kemp, JA
      Activity-dependent presynaptic autoinhibition by group II metabotropic glutamate receptors at the perforant path inputs to the dentate gyrus and CA1

      NEUROPHARMACOLOGY
    4. Knoflach, F; Mutel, V; Kew, JNC; Malherbe, P; Vieira, E; Wichmann, J; Kemp, JA
      Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    5. Malherbe, P; Knoflach, F; Broger, C; Ohresser, S; Kratzeisen, C; Adam, G; Stadler, H; Kemp, JA; Mutel, V
      Identification of essential residues involved in the glutamate binding pocket of the group II metabotropic glutamate receptor

      MOLECULAR PHARMACOLOGY
    6. Kemp, JP; Kemp, JA
      Management of asthma in Children

      AMERICAN FAMILY PHYSICIAN
    7. Kew, JNC; Koester, A; Moreau, JL; Jenck, F; Ouagazzal, AM; Mutel, V; Richards, JG; Trube, G; Fischer, G; Montkowski, A; Hundt, W; Reinscheid, RK; Pauly-Evers, M; Kemp, JA; Bluethmann, H
      Functional consequences of reduction in NMDA receptor glycine affinity in mice carrying targeted point mutations in the glycine binding site

      JOURNAL OF NEUROSCIENCE
    8. Kuner, P; Bohrmann, B; Tjernberg, LO; Naslund, J; Huber, G; Celenk, S; Gruninger-Leitch, F; Richards, JG; Jakob-Roetne, R; Kemp, JA; Nordstedt, C
      Controlling polymerization of beta-amyloid and prion-derived peptides withsynthetic small molecule ligands

      JOURNAL OF BIOLOGICAL CHEMISTRY
    9. Arora, S; Katkov, W; Cooley, J; Kemp, JA; Johnston, DE; Schapiro, RH; Podolsky, D
      Methotrexate in Crohn's disease: Results of a randomized, double-blind, placebo-controlled trial

      HEPATO-GASTROENTEROLOGY
    10. Kemp, JA; Kew, JNC; Gill, R
      NMDA receptor antagonists and their potential as neuroprotective agents

      IONOTROPIC GLUTAMATE RECEPTORS IN THE CNS
    11. Lee, M; Kemp, JA; Canning, A; Egan, C; Tataronis, G; Farraye, FA
      A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy

      ARCHIVES OF INTERNAL MEDICINE
    12. Wallace, MB; Farraye, FA; Kemp, JA
      Colonoscopy for small adenomas

      ANNALS OF INTERNAL MEDICINE
    13. Wallace, MB; Kemp, JA; Meyer, F; Horton, K; Reffel, A; Christiansen, CL; Farraye, FA
      Screening for colorectal cancer with flexible sigmoidoscopy by nonphysician endoscopists

      AMERICAN JOURNAL OF MEDICINE
    14. Kemp, JA
      Cholecystectomy and colon cancer

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    15. KEW JNC; RICHARDS JG; MUTEL V; KEMP JA
      DEVELOPMENTAL-CHANGES IN NMDA RECEPTOR GLYCINE AFFINITY AND IFENPRODIL SENSITIVITY REVEAL 3 DISTINCT POPULATIONS OF NMDA RECEPTORS IN INDIVIDUAL RAT CORTICAL-NEURONS

      The Journal of neuroscience
    16. LEFF JA; BUSSE WW; PEARLMAN D; BRONSKY EA; KEMP JA; HENDELES L; DOCKHORN R; KUNDU S; ZHANG J; SEIDENBERG BC; REISS TF
      MONTELUKAST, A LEUKOTRIENE-RECEPTOR ANTAGONIST, FOR THE TREATMENT OF MILD ASTHMA AND EXERCISE-INDUCED BRONCHOCONSTRICTION

      The New England journal of medicine
    17. SCHAFFHAUSER H; RICHARDS JG; CARTMELL J; CHABOZ S; KEMP JA; KLINGELSCHMIDT A; MESSER J; STADLER H; WOLTERING T; MUTEL V
      IN-VITRO BINDING CHARACTERISTICS OF A NEW SELECTIVE GROUP-II METABOTROPIC GLUTAMATE-RECEPTOR RADIOLIGAND, [H-3]LY354740, IN RAT-BRAIN

      Molecular pharmacology
    18. KEW JNC; KEMP JA
      AN ALLOSTERIC INTERACTION BETWEEN THE NMDA RECEPTOR POLYAMINE AND IFENPRODIL SITES IN RAT CULTURED CORTICAL-NEURONS

      Journal of physiology
    19. KNOFLACH F; KEMP JA
      METABOTROPIC GLUTAMATE GROUP-II RECEPTORS ACTIVATE A G-PROTEIN-COUPLED INWARDLY RECTIFYING K+ CURRENT IN NEURONS OF THE RAT CEREBELLUM

      Journal of physiology
    20. MUTEL V; ADAM G; CHABOZ S; KEMP JA; KLINGELSCHMIDT A; MESSER J; WICHMANN J; WOLTERING T; RICHARDS JG
      CHARACTERIZATION OF (2S,2'R,3'R)-2-(2',3'-[H-3]-DICARBOXYCYCLOPROPYL)GLYCINE BINDING IN RAT-BRAIN

      Journal of neurochemistry
    21. MUTEL V; BUCHY D; KLINGELSCHMIDT A; MESSER J; BLEUEL Z; KEMP JA; RICHARDS JG
      IN-VITRO BINDING-PROPERTIES IN RAT-BRAIN OF [H-3]RO-25-6981, A POTENTAND SELECTIVE ANTAGONIST OF NMDA RECEPTORS CONTAINING NR2B SUBUNITS

      Journal of neurochemistry
    22. KEMP JA; GILL R
      EXCITOTOXICITY IN ACUTE ISCHEMIC BRAIN INJURY

      Journal of neurochemistry
    23. WALLACE MB; HO KY; TRNKA Y; HENDERSON C; KEMP JA; FARRAYE FA
      COMPARISON OF NURSE PRACTITIONERS PHYSICIAN ASSISTANTS TO GASTROENTEROLOGISTS IN PERFORMING FLEXIBLE SIGMOIDOSCOPY

      Gastroenterology
    24. PRIESTLEY T; MARSHALL GR; HILL RG; KEMP JA
      L-687,414, A LOW EFFICACY NMDA RECEPTOR GLYCINE SITE PARTIAL AGONIST IN-VITRO, DOES NOT PREVENT HIPPOCAMPAL LTP IN-VIVO AT PLASMA-LEVELS KNOWN TO BE NEUROPROTECTIVE

      British Journal of Pharmacology
    25. KEW JNC; TRUBE G; KEMP JA
      STATE-DEPENDENT NMDA RECEPTOR ANTAGONISM BY RO-8-4304, A NOVEL NR2B SELECTIVE, NONCOMPETITIVE, VOLTAGE-INDEPENDENT ANTAGONIST

      British Journal of Pharmacology
    26. CARTMELL J; ADAM G; CHABOZ S; HENNINGSEN R; KEMP JA; KLINGELSCHMIDT A; METZLER V; MONSMA F; SCHAFFHAUSER H; WICHMANN J; MUTEL V
      CHARACTERIZATION OF (2S,2'R,3'R)-2-(2',3'-DICARBOXYCYCLOPROPYL)GLYCINE ([H-3]-DCG-IV) BINDING TO METABOTROPIC MGLU(2) RECEPTOR-TRANSFECTED CELL-MEMBRANES

      British Journal of Pharmacology
    27. RICHARDS JG; SCHAFFHAUSER H; MESSER J; BLEUEL Z; CHABOZ S; KLINGELSCHMIDT A; WICHMANN J; KEMP JA; MUTEL V
      IN-VITRO BINDING CHARACTERISTICS AND DISTRIBUTION OF THE GROUP-II METABOTROPIC RECEPTOR AGONIST [H-3]LY354740 IN RAT-BRAIN

      British Journal of Pharmacology
    28. CARTMELL J; GOEPFERT F; KNOFLACH F; PINK JR; BLEUEL Z; RICHARDS JG; SCHAFFHAUSER H; KEMP JA; WICHMANN J; MUTEL V
      EFFECT OF METABOTROPIC GLUTAMATE-RECEPTOR ACTIVATION ON RECEPTOR-MEDIATED CYCLIC-AMP RESPONSES IN PRIMARY CULTURES OF RAT STRIATAL NEURONS

      Brain research
    29. SCHAFFHAUSER H; KNOFLACH F; PINK JR; BLEUEL Z; CARTMELL J; GOEPFERT F; KEMP JA; RICHARDS JG; ADAM G; MUTEL V
      MULTIPLE PATHWAYS FOR REGULATION OF THE KCL-INDUCED [H-3]-GABA RELEASE BY METABOTROPIC GLUTAMATE RECEPTORS, IN PRIMARY RAT CORTICAL CULTURES

      Brain research
    30. WALLACE MB; KEMP JA; TRNKA YM; DONOVAN JM; FARRAYE FA
      IS COLONOSCOPY INDICATED FOR SMALL ADENOMAS FOUND BY SCREENING FLEXIBLE SIGMOIDOSCOPY

      Annals of internal medicine
    31. CHALMERSREDMAN RME; PRIESTLEY T; KEMP JA; FINE A
      IN-VITRO PROPAGATION AND INDUCIBLE DIFFERENTIATION OF MULTIPOTENTIAL PROGENITOR CELLS FROM HUMAN FETAL BRAIN

      Neuroscience
    32. CARTMELL J; KEMP JA; MUTEL V
      L-AP4 INHIBITION OF DEPOLARIZATION-EVOKED CGMP FORMATION IN RAT CEREBELLUM

      Neuroscience letters
    33. BREHM L; EBERT B; KRISTIANSEN U; WAFFORD KA; KEMP JA; KROGSGAARDLARSEN P
      STRUCTURE AND PHARMACOLOGY OF 4,5,6,7-TETRAHYDROISOTHIAZOLO[5,4-C]PYRIDIN-3-OL (THIO-THIP), AN AGONIST ANTAGONIST AT GABA(A) RECEPTORS/

      European journal of medicinal chemistry
    34. SINGH RR; KEMP JA; KOLLMORGEN JF; QURESHI JA; FINCHER GB
      FERTILE PLANT-REGENERATION FROM CELL-SUSPENSION AND PROTOPLAST CULTURES OF BARLEY (HORDEUM-VULGARE CV SCHOONER)

      Plant cell, tissue and organ culture
    35. MOHAN V; KEMP JA; LEWINE HE; RABIN M; GOLDSTEIN ML; FARRAYE FA
      DIFFUSE MESENTERIC AMYLOIDOSIS

      Digestive diseases and sciences
    36. HERTEL C; TERZI E; HAUSER N; JAKOBROTNE R; SEELIG J; KEMP JA
      INHIBITION OF THE ELECTROSTATIC INTERACTION BETWEEN BETA-AMYLOID PEPTIDE AND MEMBRANES PREVENTS BETA-AMYLOID-INDUCED TOXICITY

      Proceedings of the National Academy of Sciences of the United Statesof America
    37. FISCHER G; MUTEL V; TRUBE G; MALHERBE P; KEW JNC; MOHACSI E; HEITZ MP; KEMP JA
      RO-25-6981, A HIGHLY POTENT AND SELECTIVE BLOCKER OF N-METHYL-D-ASPARTATE RECEPTORS CONTAINING THE NR2B SUBUNIT - CHARACTERIZATION IN-VITRO

      The Journal of pharmacology and experimental therapeutics
    38. CARLING RW; LEESON PD; MOORE KW; MOYES CR; DUNCTON M; HUDSON ML; BAKER R; FOSTER AC; GRIMWOOD S; KEMP JA; MARSHALL GR; TRICKLEBANK MD; SAYWELL KL
      4-SUBSTITUTED-3-PHENYLQUINOLIN-2(1H)-ONES - ACIDIC AND NONACIDIC GLYCINE SITE N-METHYL-D-ASPARTATE ANTAGONISTS WITH IN-VIVO ACTIVITY

      Journal of medicinal chemistry
    39. ROWLEY M; KULAGOWSKI JJ; WATT AP; RATHBONE D; STEVENSON GI; CARLING RW; BAKER R; MARSHALL GR; KEMP JA; FOSTER AC; GRIMWOOD S; HARGREAVES R; HURLEY C; SAYWELL KL; TRICKLEBANK MD; LEESON PD
      EFFECT OF PLASMA-PROTEIN BINDING ON IN-VIVO ACTIVITY AND BRAIN PENETRATION OF GLYCINE NMDA RECEPTOR ANTAGONISTS/

      Journal of medicinal chemistry
    40. WALLACE M; KEMP JA; TRNKA Y; FARRAYE F
      IS COLONOSCOPY INDICATED IN PATIENTS WITH SMALL ADENOMAS ON FLEXIBLE SIGMOIDOSCOPY

      Gastroenterology
    41. KNOFLACH F; REINSCHEID RK; CIVELLI O; KEMP JA
      MODULATION OF VOLTAGE-GATED CALCIUM CHANNELS BY ORPHANIN FQ IN FRESHLY DISSOCIATED HIPPOCAMPAL-NEURONS

      The Journal of neuroscience
    42. PRIESTLEY T; LAUGHTON P; MACAULAY AJ; HILL RG; KEMP JA
      ELECTROPHYSIOLOGICAL CHARACTERIZATION OF THE ANTAGONIST PROPERTIES OF2 NOVEL NMDA RECEPTOR GLYCINE SITE ANTAGONISTS, L-695,902 AND L-701,324

      Neuropharmacology
    43. KEW JNC; TRUBE G; KEMP JA
      A NOVEL MECHANISM OF ACTIVITY-DEPENDENT NMDA RECEPTOR ANTAGONISM DESCRIBES THE EFFECT OF IFENPRODIL IN RAT CULTURED CORTICAL-NEURONS

      Journal of physiology
    44. KEW JNC; TRUBE G; KEMP JA
      AN INVESTIGATION OF THE MECHANISM OF NMDA RECEPTOR ANT AGONISM BY IFENPRODIL IN RAT CULTURED CORTICAL-NEURONS

      Journal of physiology
    45. KNOFLACH F; REINSCHEID RK; CIVELLI O; KEMP JA
      ORPHANIN FQ INHIBITION OF VOLTAGE-GATED CALCIUM CHANNELS IN RAT HIPPOCAMPAL CA3 NEURONS IN-VITRO

      Journal of physiology
    46. HERTEL C; HAUSER N; SCHUBENEL R; SEILHEIMER B; KEMP JA
      BETA-AMYLOID-INDUCED CELL TOXICITY - ENHANCEMENT OF (4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE-DEPENDENT CELL-DEATH

      Journal of neurochemistry
    47. GILL R; HARGREAVES RJ; KEMP JA
      THE NEUROPROTECTIVE EFFECT OF THE GLYCINE SITE ANTAGONIST 3R-(-CIS-4-METHYL-HA966 (L-687,414) IN A RAT MODEL OF FOCAL ISCHEMIA())

      Journal of cerebral blood flow and metabolism
    48. WAFFORD KA; KATHORIA M; BAIN CJ; MARSHALL G; LEBOURDELLES B; KEMP JA; WHITING PJ
      IDENTIFICATION OF AMINO-ACIDS IN THE N-METHYL-D-ASPARTATE RECEPTOR NR1 SUBUNIT THAT CONTRIBUTE TO THE GLYCINE BINDING-SITE

      Molecular pharmacology
    49. DANKS P; LEBOURDELLES B; MYERS J; WHITING P; KEMP JA; PRIESTLEY T
      PHARMACOLOGICAL PROFILE OF RECOMBINANT HUMAN NR1A PLUS NR2A AND NATIVE RAT CEREBELLAR GRANULE CELL NMDA RECEPTORS

      British Journal of Pharmacology
    50. PRIESTLEY T; OCHU E; KEMP JA
      SUBTYPES OF NMDA RECEPTOR IN NEURONS CULTURED FROM RAT-BRAIN

      NeuroReport
    51. WAFFORD KA; BAIN CJ; QUIRK K; MCKERNAN RM; WINGROVE PB; WHITING PJ; KEMP JA
      A NOVEL ALLOSTERIC MODULATORY SITE ON THE GABA(A) RECEPTOR-BETA SUBUNIT

      Neuron
    52. SALTZMAN JR; KEMP JA; GOLNER BB; PEDROSA MC; DALLAL GE; RUSSELL RM
      EFFECT OF HYPOCHLORHYDRIA DUE TO OMEPRAZOLE TREATMENT OR ATROPHIC GASTRITIS ON PROTEIN-BOUND VITAMIN-B-12 ABSORPTION

      Journal of the American College of Nutrition
    53. KEMP JA
      ITEMS AND DATA RELATING TO THE HISTORY AND HISTORIOGRAPHY OF PHONETICS - A PHONETIC SOURCE ATLAS - GERMAN - PANCONCELLICALZIA,G

      Historiographia linguistica
    54. PRIESTLEY T; KEMP JA
      KINETIC-STUDY OF THE INTERACTIONS BETWEEN THE GLUTAMATE AND GLYCINE RECOGNITION SITES ON THE N-METHYL-D-ASPARTIC ACID RECEPTOR COMPLEX

      Molecular pharmacology
    55. PATEL S; SMITH AJ; CHAPMAN KL; FLETCHER AE; KEMP JA; MARSHALL GR; HARGREAVES RJ; RYECROFT W; IVERSEN LL; IVERSEN SD; BAKER R; SHOWELL GA; BOURRAIN S; NEDUVELIL JG; MATASSA VG; FREEDMAN SB
      BIOLOGICAL PROPERTIES OF THE BENZODIAZEPINE AMIDINE DERIVATIVE L-740,093, A CHOLECYSTOKININ-B GASTRIN RECEPTOR ANTAGONIST WITH HIGH-AFFINITY IN-VITRO AND HIGH POTENCY IN-VIVO

      Molecular pharmacology
    56. EBERT B; WAFFORD KA; WHITING PJ; KROGSGAARDLARSEN P; KEMP JA
      MOLECULAR PHARMACOLOGY OF GAMMA-AMINOBUTYRIC-ACID TYPE-A RECEPTOR AGONISTS AND PARTIAL AGONISTS IN OOCYTES INJECTED WITH DIFFERENT ALPHA-RECEPTOR, BETA-RECEPTOR, AND GAMMA-RECEPTOR SUBUNIT COMBINATIONS

      Molecular pharmacology
    57. HADINGHAM KL; WINGROVE PB; WAFFORD KA; BAIN C; KEMP JA; PALMER KJ; WILSON AW; WILCOX AS; SIKELA JM; RAGAN CI; WHITING PJ
      ROLE OF THE BETA-SUBUNIT IN DETERMINING THE PHARMACOLOGY OF HUMAN GAMMA-AMINOBUTYRIC-ACID TYPE-A RECEPTORS (VOL 44, PG 1211, 1993)

      Molecular pharmacology
    58. LEBOURDELLES B; WAFFORD KA; KEMP JA; MARSHALL G; BAIN C; WILCOX AS; SIKELA JM; WHITING PJ
      CLONING, FUNCTIONAL COEXPRESSION, AND PHARMACOLOGICAL CHARACTERIZATION OF HUMAN CDNAS ENCODING NMDA RECEPTOR NR1 AND NR2A SUBUNITS

      Journal of neurochemistry
    59. SHOWELL GA; BOURRAIN S; NEDUVELIL JG; FLETCHER SR; BAKER R; WATT AP; FLETCHER AE; FREEDMAN SB; KEMP JA; MARSHALL GR; PATEL S; SMITH AJ; MATASSA VG
      HIGH-AFFINITY AND POTENT, WATER-SOLUBLE 5-AMINO-1,4-BENZODIAZEPINE CCK(B) GASTRIN RECEPTOR ANTAGONISTS CONTAINING A CATIONIC SOLUBILIZING GROUP

      Journal of medicinal chemistry
    60. BOCK MG; DIPARDO RM; MELLIN EC; NEWTON RC; VEBER DF; FREEDMAN SB; SMITH AJ; PATEL S; KEMP JA; MARSHALL GR; FLETCHER AE; CHAPMAN KL; ANDERSON PS; FREIDINGER RM
      2ND-GENERATION BENZODIAZEPINE CCK-B ANTAGONISTS - DEVELOPMENT OF SUBNANOMOLAR ANALOGS WITH SELECTIVITY AND WATER SOLUBILITY

      Journal of medicinal chemistry
    61. KULAGOWSKI JJ; BAKER R; CURTIS NR; LEESON PD; MAWER IM; MOSELEY AM; RIDGILL MP; ROWLEY M; STANSFIELD I; FOSTER AC; GRIMWOOD S; HILL RG; KEMP JA; MARSHALL GR; SAYWELL KL; TRICKLEBANK MD
      (ARYLMETHYL)-3-PHENYL-4-HYDROXYQUINOLIN-2(1H)-ONES AND 3'-(ARYLOXY)-3-PHENYL-4-HYDROXYQUINOLIN-2(1H)-ONES - ORALLY-ACTIVE ANTAGONISTS OF THE GLYCINE SITE ON THE NMDA RECEPTOR

      Journal of medicinal chemistry
    62. BROWN NA; KEMP JA; SEABROOK GR
      BLOCK OF HUMAN VOLTAGE-SENSITIVE NA-SY5Y CELLS BY LIFARIZINE( CURRENTS IN DIFFERENTIATED SH)

      British Journal of Pharmacology
    63. PRIESTLEY T; OCHU E; KEMP JA
      IFENPRODIL AND CGS-19755 DISCRIMINATE BETWEEN CORTICAL AND CEREBELLARNMDA RECEPTORS

      British Journal of Pharmacology
    64. WINGROVE PB; WAFFORD KA; BAIN C; KEMP JA; WHITING PJ
      IDENTIFICATION OF A SINGLE AMINO-ACID ON THE BETA-SUBUNIT OF THE GABA(A) RECEPTOR REQUIRED FOR THE MODULATORY ACTION OF LORECLEZOLE

      British Journal of Pharmacology
    65. SEABROOK GR; MCALLISTER G; KNOWLES MR; MYERS J; SINCLAIR H; PATEL S; FREEDMAN SB; KEMP JA
      DEPRESSION OF HIGH-THRESHOLD CALCIUM CURRENTS BY ACTIVATION OF HUMAN D-2 (SHORT) DOPAMINE-RECEPTORS EXPRESSED IN DIFFERENTIATED NG108-15 CELLS

      British Journal of Pharmacology
    66. SEABROOK GR; KEMP JA; FREEDMAN SB; PATEL S; SINCLAIR HA; MCALLISTER G
      FUNCTIONAL EXPRESSION OF HUMAN D-3 DOPAMINE-RECEPTORS IN DIFFERENTIATED NEUROBLASTOMA-X-GLIOMA NG108-15 CELLS

      British Journal of Pharmacology
    67. CARTMELL J; KEMP JA; ALEXANDER SPH; SHINOZAKI H; KENDALL DA
      MODULATION OF CYCLIC-AMP FORMATION BY PUTATIVE METABOTROPIC RECEPTOR AGONISTS

      British Journal of Pharmacology
    68. PROVENZALE D; KEMP JA; ARORA S; WONG JB
      A GUIDE FOR SURVEILLANCE OF PATIENTS WITH BARRETTS-ESOPHAGUS

      The American journal of gastroenterology
    69. WAFFORD KA; BAIN CJ; LEBOURDELLES B; WHITING PJ; KEMP JA
      PREFERENTIAL COASSEMBLY OF RECOMBINANT NMDA RECEPTORS COMPOSED OF 3 DIFFERENT SUBUNITS

      NeuroReport
    70. HADINGHAM KL; WINGROVE PB; WAFFORD KA; BAIN C; KEMP JA; PALMER KJ; WILSON AW; WILCOX AS; SIKELA JM; RAGAN CI; WHITING PJ
      ROLE OF THE BETA-SUBUNIT IN DETERMINING THE PHARMACOLOGY OF HUMAN GAMMA-AMINOBUTYRIC-ACID TYPE-A RECEPTORS

      Molecular pharmacology
    71. PRIESTLEY T; KEMP JA
      AGONIST RESPONSE KINETICS OF N-METHYL-D-ASPARTATE RECEPTORS IN NEURONS CULTURED FROM RAT CEREBRAL-CORTEX AND CEREBELLUM - EVIDENCE FOR RECEPTOR HETEROGENEITY

      Molecular pharmacology
    72. WAFFORD KA; BAIN CJ; WHITING PJ; KEMP JA
      FUNCTIONAL COMPARISON OF THE ROLE OF GAMMA-SUBUNITS IN RECOMBINANT HUMAN GAMMA-AMINOBUTYRIC ACID(A) BENZODIAZEPINE RECEPTORS

      Molecular pharmacology
    73. LEBOURDELLES B; WAFFORD KA; GRIMWOOD S; ROWE JM; KEMP JA; RAGAN CI; WHITING PJ
      MOLECULAR-CLONING AND EXPRESSION OF HUMAN NMDA RECEPTOR SUBUNITS

      Journal of neurochemistry
    74. CARTMELL J; KEMP JA; ALEXANDER SPH; KENDALL DA
      A COMPARISON OF THE EFFECTS OF SELECTIVE METABOTROPIC EAA RECEPTOR AGONISTS ON 2ND MESSENGER PATHWAYS

      Journal of neurochemistry
    75. LEBOURDELLES B; WAFFORD KA; GRIMWOOD S; ROWE JM; KEMP JA; RAGAN CI; WHITING PJ
      MOLECULAR-CLONING AND EXPRESSION OF HUMAN NMDA RECEPTOR SUBUNITS

      Journal of neurochemistry
    76. PRIESTLEY T; KEMP JA
      FUNCTIONAL EVIDENCE FOR DIFFERENT NMDA RECEPTOR SUBTYPES IN NEURONS CULTURED FROM 2 REGIONS OF RAT-BRAIN

      Journal of neurochemistry
    77. CARTMELL J; KEMP JA; ALEXANDER SPH; KENDALL DA
      2ND MESSENGER RESPONSES TO EAA AGONISTS IN GUINEA-PIG CEREBRAL CORTICAL SLICES

      Journal of neurochemistry
    78. KEMP JA; PRIESTLEY T; ROWLEY M; LEESON PD
      DIFFERENCES BETWEEN THE ELECTROPHYSIOLOGICAL PROPERTIES OF 7-CHLOROKYNURENIC ACID AND A NEW GLYCINE-SITE ANTAGONIST, L-695,902

      Journal of neurochemistry
    79. ROWLEY M; LEESON PD; STEVENSON GI; MOSELEY AM; STANSFIELD I; SANDERSON I; ROBINSON L; BAKER R; KEMP JA; MARSHALL GR; FOSTER AC; GRIMWOOD S; TRICKLEBANK MD; SAYWELL KL
      3-ACYL-4-HYDROXYQUINOLIN-2(1H)-ONES - SYSTEMICALLY ACTIVE ANTICONVULSANTS ACTING BY ANTAGONISM AT THE GLYCINE SITE OF THE N-METHL-D-ASPARTATE RECEPTOR COMPLEX

      Journal of medicinal chemistry
    80. CARLING RW; LEESON PD; MOORE KW; SMITH JD; MOYES CR; MAWER IM; THOMAS S; CHAN T; BAKER R; FOSTER AC; GRIMWOOD S; KEMP JA; MARSHALL GR; TRICKLEBANK MD; SAYWELL KL
      3-NITRO-3,4-DIHYDRO-2(1H)-QUINOLONES - EXCITATORY AMINO-ACID ANTAGONISTS ACTING AT GLYCINE-SITE NMDA AND LPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID RECEPTORS

      Journal of medicinal chemistry
    81. PROVENZALE D; KEMP JA; ARORA S; WONG JB
      AN UNCERTAIN CANCER RISK IN PATIENTS WITH BARRETT-ESOPHAGUS - CAN DECISION-ANALYSIS GUIDE OUR PRACTICE

      Gastroenterology
    82. CAESER M; SEABROOK GR; KEMP JA
      BLOCK OF VOLTAGE-DEPENDENT SODIUM CURRENTS BY THE SUBSTANCE-P RECEPTOR ANTAGONIST (+ -)-CP-96,345 IN NEURONS CULTURED FROM RAT CORTEX/

      British Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/02/20 alle ore 18:48:33